Related Experiment Video
Updated: Aug 3, 2026
13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Multi-targeting the entrance door to block HIV-1
1Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.
Current Drug Targets. Infectious Disorders
|March 22, 2005
Summary
Blocking human immunodeficiency virus type 1 (HIV-1) entry offers therapeutic advantages. Targeting multiple viral entry and life cycle steps with single agents can enhance efficacy and reduce resistance.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Human immunodeficiency virus type 1 (HIV-1) entry into host cells is a complex, multistep process.
- Blocking viral entry presents a strategic advantage over targeting later stages of the HIV-1 life cycle.
- In vitro studies demonstrate synergistic inhibition of HIV-1 proliferation with entry inhibitor combinations.
Purpose of the Study:
- To review the multistep process of HIV-1 cell entry.
- To discuss the current inhibitors targeting HIV-1 cell entry.
- To introduce a novel multisite HIV-1 targeting strategy.
Main Methods:
- Literature review of HIV-1 cell entry mechanisms.
- Analysis of existing HIV-1 entry inhibitors.
- Presentation of a conceptual framework for multisite targeting.
Main Results:
- HIV-1 entry involves multiple critical steps amenable to therapeutic intervention.
- Combinations of entry inhibitors show cooperative and synergistic effects.
- Multisite targeting, including entry and subsequent steps, is proposed as a superior therapeutic approach.
Conclusions:
- Targeting multiple sites and steps in the HIV-1 life cycle offers enhanced therapeutic potential.
- Single agents capable of multisite targeting could simplify clinical use and combat resistance.
- Developing drugs that target both viral entry and subsequent stages is a promising strategy for effective HIV-1 treatment.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...